KULDEEP KAUR: Open Payments
NPI 1538940002 · BELLEVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$223 in 12 payments from 7 companies in 2025. Trend: 2023 $16 · 2024 $85 · 2025 $223
Food & beverage: $223
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 5 | $91 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| BIOTRONIK INC. | 1 | $23 |
| Lilly USA, LLC | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
Products named: APRETUDE, CABENUVA, BIOMONITOR, AREXVY, TRELEGY ELLIPTA, DOVATO, MOUNJARO, XIFAXAN.
Industry payments across NJ — which companies pay providers there.
